Healthcare & Life Sciences

Hookipa Pharma

series-c-plus
series-c-plus
Stage
2
Investors

About

Hookipa Pharma is a clinical-stage biotechnology company developing immunotherapies and vaccines using a proprietary arenavirus-based platform (VaxWave) to induce T-cell and antibody responses for infectious diseases and oncology.

Explore Hookipa Pharma's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.